| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $42.1M | +22.9% |
| SG&A Expense | $25.7M | +33.6% |
| Operating Income | -$83.0M | -55.2% |
| Net Income | -$72.9M | -40.6% |
| EPS (Basic) | -$2.42 | +31.8% |
| EPS (Diluted) | -$2.42 | +31.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $175.5M | +755.2% |
| Short-term Investments | $71.0M | -65.5% |
| Current Assets | $250.9M | +10.2% |
| Total Assets | $254.7M | +10.4% |
| Current Liabilities | $11.6M | +27.5% |
| Total Liabilities | $11.6M | +22.7% |
| Stockholders' Equity | $243.1M | +9.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$68.4M | -57.2% |
| Capital Expenditures | $25K | -72.5% |
| Investing Cash Flow | $135.1M | +180.8% |
| Financing Cash Flow | $88.4M | -38.9% |
| Free Cash Flow | -$68.5M | -57.0% |